Eficácia e segurança de sistemas de circuito fechado híbridos em crianças com < 7 anos de idade com diabetes tipo 1: uma revisão sistemática e metanálise de ensaios clínicos randomizados
EndocrinologiaResumo original em inglês
O que aconteceu
This study aimed to evaluate the clinical efficacy and safety of hybrid closed-loop systems for glycemic control in children aged p p p = 0.11). A comparison of serious adverse events showed no statistically significant differences in the risk of diabetic ketoacidosis (p = 0.50) and severe hypoglycemia (p = 0.64) between the hybrid closed-loop system group and the conventional therapy group. The hybrid closed-loop system can effectively improve glycemic control in children under 7 years old with Type 1 diabetes without increasing the risk of adverse events. Further high-quality, large-sample clinical studies are still required to verify and supplement the present conclusions.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials
Tingting Zhang, Na Wang, Bo Wang, Menghao Wang, Jia Zhang
Descritores MeSH
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems
- Diabetes Mellitus, Type 1
- Glycemic Control
- Humans
- Hypoglycemia
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Blood Glucose
Veja também
Estudos relacionados
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Efficacy and Safety of iLet Bionic Pancreas in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta Analysis
- Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- Clinical evidence for high-risk CE-marked medical devices for glucose management: A systematic review and meta-analysis